Introduction
Non steroidal anti-inflammatory drugs (NSAIDs) represent one of the most common classes of medications used worldwide with an estimated usage of >30 million per day 1 . Some are available over the counter and likely to be abused. NSAIDs exert anti-inflammatory, analgesic and antipyretic effects through the suppression of prostaglandin (PG) synthesis by inhibiting the enzyme cyclo-oxygenase 1and 2 (COX 1 and 2) 1 . Serious gastrointestinal side effects have been minimized with the advent of selective and specific cox-2 inhibitors and misoprostol. However the newer NSAIDs continue to be nephrotoxic much like the conventional ones 1,2 . It can induce two different forms of acute kidney injury (AKI) haemodynamically mediated and acute interstitial nephritis (AIN) which is often accompanied by nephrotic syndrome 2 . In patients on long term
NSAIDs without acute or chronic renal failure, subclinical renal dysfunction such as reduced creatinine clearance and impaired urine concentrating ability has been shown to be present. Although this subclinical dysfunction is reversible on withdrawl of NSAIDs, some reports have suggested a persistent residual dysfunction 3 .
taking NSAIDs for different reasons within past 15 days were included in this study irrespective of their age, sex and social background. Any patient having pre existing renal pathology, chronic kidney disease or taking any other nephrotoxic medication concomittently was excluded from this study.
Patients were evaluated in terms of demography, aetiology, mode of presentation, clinical and laboratory findings, treatment pattern, complications and prognosis including follow-up for at least next six months. Rising of serum creatinine >1.4 mg/dl following taking NSAID was considered as AKI. Management schedule was conventional for all the patients to treat the disease, its complications and follow prognosis.
Results
Mean age of the total 59 patients evaluated was 36±7.12 yrs. 48 were male (81.36%) whereas 11 were female (18.64%). 45 patient (76.27%) took NSAIDs at their own and 14 patients (23.73%) were prescribed by physician. 3 of them (5.09%) received NSAIDs in intravenous (IV) or intramuscular (IM) route (Table-I) . Table-IV) .
Table-IV: Predisposing factors (n=59).
Most of the symptoms in NSAIDs induced AKI were vague and mostly revealed on leading question. Oliguria was present in six patients (10.17%). Nineteen patients (32.20%) had headache whereas 16 patients (27.12%) complained of fatigue. Nausea or vomiting was the presenting feature in eight patients (13.56%). Oedema was the most common sign (24 patients). Two patients (3.39%) had haematuria and raised BP was found in six (10.17%) patients. NSAIDs induced AKI was diagnosed incidentally in 17 patients (28.81%) basing on laboratory findings as there was no definitive sign or symptoms ( Table-V As usual serum urea & creatinine were raised in all patients. In urine, pyuria (leucocyturia) was found in 18 patients (30.51%). RBC was found in 11 patients (18.64%). 24 hrs urinary total protein was raised (<1 gm) in 20 patients (33.90%). S. potassium (k+) was raised in 21 patients (33.59%). In ultrasonography (USG), six patients (10.17%) had swollen kidney ( Table-VI) .
Table-VI: Laboratory Findings (n=59).
In all cases, 100% withdrawal of drug was ensured. Fluid resuscitation was given in 51 patients and restriction was carried out in eight patients who had fluid overload. Steroid (prednisolone) was given in eight patients (13.55%) for a short period (2-4 wks).Two of them required IV methyl prednisolone for initial three days due to severe renal failure and unable to take oral medication due to vomiting. Six patients required haemodialysis ( Table-VII) . In this study, mean duration of therapy to develop AKI was 6±2.17 days for diclofenac and 4±1.89 days for naproxen. Since typically administered NSAIDs can be systematically absorbed such therapy should also be terminated in suspected cases 10 . NSAIDs increase the risk of AKI particularly in the elderly with multiple co-morbidities and the use of the combination of ACE inhibitors, angiotensin II blockers, diuretics and NSAIDs. Regular use of either aspirin or acetaminophen was associated with 2.5 fold increase in the risk of CKD 11 . We found fluid depleted state like gastroenteritis, vomiting as the common predisposing factor (15.25%) after physical exertion in hot and humid weather (30.51%). Surprisingly patient developed AKI when kept NPO and on IV fluid may be due to inadequate infusion (5.09%). No predisposing factor could be ascertained in most of the cases (42.37%) in this study.
NSAIDs induced AKI is commonly haemo dynamically mediated, diagnosis of which is mostly incidental as found in our study (28.81%) as the symptom like fatigue, headache, polyuria, nausea are subjective and vague. But the clinical presentation of AIN is more specific like acute onset oedema, oliguria and sometimes anuria. Macroscopic haematuria is rare. Urine analysis reveals proteinuria, microscopic haematuria and leucocyturia. Serum creatinine varies from minimal elevation (1.5 mg/dl) to > 10 mg/dl at first presentation. In our study, leucocyturia was found in 18 patients (30.51%) whereas microscopic haematuria was present in 11 patient (18.64%). Urinary total protein was raised (<1 gm) in 20 patients (33.90%).
Raised serum urea and creatinine were found in all patients (100% 
Conclusion
NSAIDs are associated with all forms of renal injury while acute syndromes generally carry a good prognosis; the same is not true for CKD. Subclinical CKD can be a silent forerunner of CKD. Analgesic toxicity can be prevented by limiting the availability of over the counter NSAIDs. Physicians should always prescribe the lowest effective dose of NSAIDs for the shortest possible time ensuring adequate hydration 16 .
